Catalysts which have low antimicrobial toxicity and are aprotic, yet which can act as Brønsted acidic catalysts in the presence of protic additives have been developed. The catalysts are recyclable, considerably more active (i.e. can be used at 10–50 times lower loadings) and of broader scope than their antecedent generation.
No takes yet. Share an insight, caveat, or question.
Myles et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: